Pelvic organ prolapse ("POP") occurs when the muscles and ligaments supporting a woman's pelvic organs weaken and slip out of place. Because of the sensitivities involved, there is very little talk about this issue in the media or even in private conversation. But it is a very common problem. Approximately 50% of women - a statistic few people seem to focus on - who have children will suffer some type of prolapse over the course of their lives and nearly 10% of women will need surgery for pelvic organ prolapse.
Vaginal mesh implants were seen as a revolution in dealing with POP, helping women avoid more invasive retropubic placement. The idea of vaginal mesh implants was conceived in France in the late 90s and requires the placing of a sling via the groin and obturator foramen of the bony pelvis. The first European product was a polypropylene mesh with a silicone coated sub-urethral zone called Uratape. Uratape failed and was withdrawn from the market because of a high incidence of vaginal mesh extrusion and replaced with ObTape. But Mentor's ObTape and Avaulta's vaginal mesh slings, the two big replacements for Uratape, were not much of an improvement.
The Avaulta vaginal sling consists of a thermally linked monofilament polypropylene fiber with small pores. The Avaulta pelvic sling is non-woven which makes it relatively stiff. The Avaulta lawsuits claim the mesh users have suffered an erosion of the mesh into the vaginal wall causing tearing, cutting, and sometimes permanent erosion of the vaginal tissues at levels that are unacceptable, and that its manufacturer should have known about from the Uratape example. The lawsuits also claim the product needed more testing and analysis before Avaulta put its sling on the market.
Thousands of women remain implanted with the vaginal mesh implants and suffer from or at risk of suffering from vaginal mesh extrusion. There are Avaulta transvaginal pelvic mesh lawsuits pending around the country. You may be able to receive money for your pain and suffering, lost wages, medical bills, and other damages related to your Avaulta mesh complications. Lawsuits are never a sure thing but we believe many of these claims are quality cases.
A New Jersey state court jury awarded a total of $68 million to a woman who sued Bard claiming that she was harmed by Bard Medical's Align and Avaulta transvaginal mesh products.
Doctors implanted the mesh in 2009 to treat stress urinary incontinence and pelvic prolapse. The jury was hard on C.R Bard. They found both"malicious intent" or "wanton and willful disregard" in selling these devices in spite of the risks to undisclosed risks to women.
While many of these lawsuits have settled, there are still many pending, including over 100 claims in New Jersey state court alone.
Our firm is not reviewing new vaginal mesh cases.